Mediators of Inflammation / 2018 / Article / Fig 5

Research Article

Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia

Figure 5

Icaritin is the active ingredient that improves the abnormal proliferation of megakaryocytes and invokes the TPO/MPL axis in the bone marrow of ITP mice. (a) HE staining of the bone marrow. Black arrows indicate megakaryocytes. (b) Icaritin decreased the number of megakaryocytes in the bone marrow of ITP mice. (c) TPO immunohistochemical staining in the bone marrow. (d) Icaritin inhibited TPO protein expression. (e) MPL immunohistochemical staining in the bone marrow. (f) Icaritin decreased MPL protein expression in megakaryocytes. (g) p-Stat3 immunohistochemical staining in the bone marrow. (h) Icaritin inhibited p-Stat3 protein expression in megakaryocytes. Data are presented as the mean ± SEM ( per group). Scale bar = 50 μm, ×200. One-way ANOVA was used to analyze the difference among the groups. and versus control group; , , and versus model group.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.